ベインのウェブサイトは、ユーザーの、利便性の向上、と機能改善のために、クッキーを使用しています。詳細は、弊社のプライバシーポリシーをご参照ください。このサイト閲覧を継続されることで、クッキーの使用についてご了承いただいたことになります。

スナップチャート

Healthcare Corporations Lean More on M&A to Boost Revenues

Revenue growth has edged out price-to-earnings multiple expansion as the largest source of total shareholder return.

  • 2019年5月21日

スナップチャート

Healthcare Corporations Lean More on M&A to Boost Revenues

The disclosed value of healthcare corporate M&A grew 31% in 2018 to an all-time high of $435 billion, partly on the back of two megamergers that accounted for about one-third of total value. As price-to-earnings multiple expansion slows and pressure against rising healthcare prices intensifies, we expect public healthcare companies to lean more on acquisitions to grow revenues. Our analysis of total shareholder return for public healthcare companies finds that revenue growth has been the single biggest driver of TSR over the past five-, three- and one-year periods ending in 2018. To maximize the value of M&A in this high-valuation environment, companies will need to craft an airtight integration thesis.

Nirad Jain and Kara Murphy are partners with Bain & Company and coleaders of the firm’s Healthcare Private Equity team.

Related Report

Corporate M&A: Healthcare Acquisitions Feed Revenue Growth

To maximize value, companies need an airtight integration thesis.

Tags

お気軽にご連絡下さい

私達は、グローバルに活躍する経営者が抱える最重要経営課題に対して、厳しい競争環境の中でも成長し続け、「結果」を出すために支援しています。